The Supreme Court refused the Trump administration’s emergency request to restrict transgender medical treatments for federal prison inmates, leaving a lower-court block intact in what the White House called a loss for common sense.

In a brief order issued Wednesday, the justices turned away the administration’s bid to lift an injunction against a Bureau of Prisons policy that would end hormone treatments, gender transition surgery, and related social accommodations for inmates in federal custody. The order offered no explanation. Justices Clarence Thomas and Samuel Alito said they would have granted the request.

NBC News reported the administration therefore cannot enforce the policy while lower-court litigation continues. Roughly 1,000 transgender inmates are held in the federal system. The fight centers on whether taxpayers must keep funding contested medical interventions behind bars.

White House spokeswoman Allison Schuster did not say much after the setback. She said the order was a loss for common sense and vowed the administration would keep working to protect Americans from dangerous, life-altering medical practices.

"This order is a loss for common sense."

The policy flowed from President Trump’s January 2025 executive order directing federal agencies to recognize only the immutable biological classification of male or female. Over the last 18 months the Bureau of Prisons announced it would no longer provide transition surgery, hormone treatments, or social accommodations such as wigs, padding, or makeup. If the rules took effect, inmates would still receive mental health services and, in some cases, medications like antidepressants.

Lower courts froze the common-sense rollback

U.S. District Judge Royce Lamberth, a Reagan appointee based in Washington, blocked the policy earlier this year. He faulted the government for citing “zero evidence from its own medical or mental health professionals” to support the Program Statement, even though the agency had provided gender-affirming care for years.

"Despite providing gender-affirming care to inmates in its custody for years, the government cites in the Program Statement zero evidence from its own medical or mental health professionals to support its conclusions."

Lamberth also found no evidence the prior plan was “ineffective or harmful” and said the change appeared engineered to match the president’s order. The New York Post noted that assessment as the core of the district ruling that remains in force.

In September the U.S. Court of Appeals for the District of Columbia Circuit refused, 2-1, to stay Lamberth’s final decision. Solicitor General D. John Sauer told the Supreme Court the lower court was “substituting its own policy judgment for that of the agency.” The justices declined to intervene on the emergency docket.

That hands-off posture fits a larger pattern of high-stakes fights over the Court’s direction, including moments when Kagan faulted the conservative majority for decisions she argued weakened democratic norms.

The Washington Examiner described the outcome as a 7-2 denial of the Justice Department’s emergency petition. Only Thomas and Alito would have lifted the injunction so the policy could take effect during the ongoing case.

ACLU frames care as a constitutional right

Lead plaintiffs Alishea Kingdom, Jas Kapule, and Solo Nichols are transgender inmates who have received hormone treatment for several years. The American Civil Liberties Union represents them and argued the abrupt policy shift violated the Eighth Amendment ban on cruel and unusual punishment. ACLU lawyer Li Nowlin-Sohl called the Supreme Court action critical for clients and all transgender people in Bureau of Prisons custody.

"The denial of medically necessary health care, including gender-affirming health care, to people in prison is a violation of their fundamental constitutional rights."

ACLU court papers claimed hormone therapy has been available to inmates since 1992 and said the sudden change without adequate explanation “gives rise to the inference that the agency’s purported reasons were not its actual reasons.” They further argued the rationales were “contrived to support the demand President Trump made” in the executive order. The government has maintained that medical professionals have recently called such treatments into question, a claim transgender rights advocates heavily contest.

Prison management is not a classroom debate. The National Review argued that judicial flyspecking of executive prison policy after a lengthy administrative process is harmful and especially counterproductive in a volatile prison setting. Lower courts had blocked Bureau of Prisons regulations issued after a massive administrative record.

Conservative justices have faced sustained pressure in other landmark fights; Alito has described the courage required when threats and harassment followed the Dobbs decision. That context makes the silence of the majority here all the more striking.

Biological sex rules meet judicial second-guessing

The blocked Bureau of Prisons approach tracked Trump’s day-one order restoring biological truth in federal policy. Breitbart reported Schuster’s fuller statement that the president has fought from the first day in office to halt U.S. taxpayer funding of transgender procedures for prison inmates and the waste of resources on so-called social accommodations.

The same Court has recently backed state bans on transgender athletes in women’s and girls’ sports and, a year earlier, state laws barring gender transition treatments for minors. It has also allowed the Trump administration’s ban on transgender people serving in the military. Those rulings recognized sex-based lines. This emergency denial leaves federal prisons under a different standard while the lawsuit grinds on.

Other emergency matters have gone the administration’s way, including when the Supreme Court let Trump restart third-country deportations. The contrast underlines how uneven the emergency docket can feel when biological reality and taxpayer costs collide with lower-court injunctions.

The case continues in the lower courts. For now the injunction stands, the policy stays frozen, and the Bureau of Prisons cannot implement the limits it announced. Inmates who already receive hormones remain under the prior regime. The administration has made clear it will keep pressing the issue.

Voters who expect secure institutions and honest accounting of biological sex will watch whether courts keep substituting their preferences for elected policy in the one place where order and clarity matter most, behind prison walls.